Runner

Patients with PCD are no less likely to be susceptible to allergies than any other individual, but occasionally atopy may co-exist and complicate or worsen the signs and symptoms they suffer.

Such patients might benefit from typical asthma therapies in conjunction with their other treatments for PCD.

Patients with chronic lung diseases can, however, be susceptible to a specific allergy to a fungal organism called aspergillus fumigates. This condition, called Allergic Bronchopulmonary Aspergillosis or ABPA, may present with shortness of breath, wheeze and feelings of chest tightness.

There may be a fall in lung function that is difficult to reverse with the usual treatments. All these symptoms are not typical of PCD alone, and so ABPA should be looked for using both sputum and blood tests to diagnose it.

Treatment involves a combination of anti-fungal agents and a limited course of oral steroids.

It is possible to reverse the features with treatment, but like many allergic conditions there may be exacerbations that need further treatment courses.